From a young age, Janiah Monroe knew she was a girl. Growing up on Chicago’s South Side, she loved jumping rope with her female cousins and playing with their hair.
But Janiah was assigned male at birth. Her family thought she was supposed to act and look like a boy. Her father, a pastor, would beat her when she was too feminine. Janiah hated being perceived as a boy — hated her body and her voice. She struggled continually with shame, anxiety and gender dysphoria.
Fast forward to 2008. Janiah was 16 and incarcerated under the custody of the Illinois Department of Corrections (IDOC) in a male facility. She told the IDOC she identified as transgender and requested hormone therapy, among other treatments. But the IDOC denied her request, saying it didn’t provide hormone therapy to inmates who weren’t legally taking hormones prior to incarceration.
Janiah called the denial of treatment “excruciatingly painful.” It drove her to severe self-harm, including suicide attempts.
After several more unsuccessful requests for treatment, the IDOC allowed Janiah to begin hormone therapy in 2012. While the hormones helped Janiah to an extent, she described the treatments as “putting a Band-Aid on a wound that needs stitches.”
Janiah continued to be housed in male facilities for the first 10 years of her incarceration. She was routinely subjected to verbal harassment, physical assaults, and sexual abuse by inmates and officers.
Janiah is one of five transgender women prisoners on behalf of whom Kirkland and the American Civil Liberties Union (ACLU) of Illinois filed a putative class action against IDOC officials in January 2018.
In the suit, Janiah Monroe, et al. v. Bruce Rauner, et al., the plaintiffs claimed that IDOC officials improperly denied adequate treatment for their diagnosed gender dysphoria, which violated their Eighth Amendment rights. They asserted that the IDOC routinely and arbitrarily delayed or denied necessary forms of medical care, including hormone therapy, social transition (e.g., gender-affirming clothing, grooming items and use of pronouns) and evaluation for gender-affirming surgery.
Additionally, within the IDOC, a centralized “Transgender Committee” — whose members had no medical training or gender dysphoria expertise — was in charge of managing the plaintiffs’ medical treatment. The plaintiffs were assessed and treated by health care providers who also had no expertise or proper training in assessing or treating gender dysphoria.
“I was shocked and appalled to hear about the treatment [transgender prisoners] are subjected to both at a systemic level and on a day-to-day basis with individual guards and certain medical professionals,” said Chicago litigation associate Amelia Bailey, a member of the Kirkland team on the case.
Kirkland and the ACLU of Illinois sought the court to require the IDOC to reform its medical care system to treat transgender prisoners humanely and consistently with the well-established medical standards for treating gender dysphoria.
“The IDOC routinely flouts its constitutional obligations to provide transgender prisoners the medical treatment they need,” said John Knight, director of the LGBTQ & HIV Project at the ACLU of Illinois.
“People are suffering and dying because of the devastating inadequacies in the delivery of health care to this vulnerable population,” Knight added.
Kirkland and the ACLU of Illinois filed a motion for a preliminary injunction requesting immediate relief in the U.S. District Court for the Southern District of Illinois. The team argued the motion at a two-day evidentiary hearing.
In December 2019, the team achieved a sweeping victory when the court granted the plaintiffs’ motion and ordered nearly all of the requested relief, including that the IDOC:
According to the World Professional Association for Transgender Health (WPATH), these are the minimum qualifications a mental health professional must attain in order to assess and treat gender dysphoria:
“This victory is of great significance as it establishes policies to discontinue the institutional and systemic discrimination against transgender prisoners in the Illinois prison system,” said Chicago IP litigation partner Jordan Heinz, a lead member of the Kirkland team on the case.
“The court order, if IDOC complies, will lead to meaningful reform ensuring that all transgender prisoners with gender dysphoria are provided with the necessary medical treatment they deserve,” Heinz continued.
Kirkland’s tireless determination and steadfast commitment to advancing the rights of the LGBTQ+ community through impactful pro bono work continues. With this important victory, Kirkland has helped to further safeguard the physical safety and mental health of transgender individuals in the IDOC.
The case is ongoing. In March 2020, the court granted class certification and amended its preliminary injunction, ordering the IDOC to immediately ensure that timely hormone therapy is provided when medically necessary, including the administration of hormone dosage adjustments, and to perform routine monitoring of hormone levels.
“Kirkland’s involvement in the case will have fostered significant improvements in the wellbeing of the transgender community once IDOC fully complies with the court order,” said Heinz. “Kirkland attorneys remain committed to deepening their ties with the broader LGBTQ+ community through this type of pro bono work concerned with LGBTQ+ rights.”